Sort
51,593 grants matching “hepatitis”
Novel Interferons and small molecule enhancers of the interferon pathway
$484,317Kenan Christopher Garcia · Stanford University · U19 · FY2014 · AI
Role of neutrophil-specific NOX2 in alcohol-induced liver injury
$484,308Cynthia Ju · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AA
The Effect of TCF7L2 on Glucose Metabolism
$484,280Adrian Vella · Mayo Clinic Rochester · R01 · FY2013 · DK
Copper and copper-binding proteins in insulin resistance-associated metabolic disease
$484,276Ji Miao · Boston Children'S Hospital · R01 · FY2022 · DK
Copper and copper-binding proteins in insulin resistance-associated metabolic disease
$484,274Ji Miao · Boston Children'S Hospital · R01 · FY2023 · DK
Copper and copper-binding proteins in insulin resistance-associated metabolic disease
$484,274Ji Miao · Boston Children'S Hospital · R01 · FY2025 · DK
RBP2 Biology and Pathobiology
$484,240William S Blaner · Columbia University Health Sciences · R01 · FY2021 · DK
Heptax for Alcoholic Liver Disease
$484,221Fredric J. Pashkow · Cardax Pharmaceuticals, Inc. · R44 · FY2011 · AA
Novel signaling pathways regulated by the liver x receptor in age-related macular degeneration
$484,209Goldis Malek · Duke University · R01 · FY2019 · EY
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction
$484,186Joshua Wiley Knowles · Stanford University · R01 · FY2023 · DK
Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity
$484,158Steven William Hetts · University Of California, San Francisco · R01 · FY2019 · CA
Regulation of drug metabolizing enzymes by miRNAs
$484,156Todd C. Skaar · Indiana University Indianapolis · R01 · FY2016 · GM
Aldehydes in Alcohol-Induced Organ Injury
$484,101Zhanxiang Zhou · University Of North Carolina Greensboro · R01 · FY2011 · AA
STRA6 and Ocular Vitamin A Homeostasis
$484,030Johannes Friedrich Von Lintig · Case Western Reserve University · R01 · FY2020 · EY
Management/Hepatitis C/HIV-infected and Uninfected IDU's
$483,899Johns Hopkins University · R01 · FY2005 · DA
Metagenomic detection of emerging viruses in the blood supply
$483,882Eric L. Delwart · Vitalant · R01 · FY2015 · HL
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans
$483,871Nathan Oliver Stitziel · University Of Washington · P01 · FY2020 · HL
Development of Advanced C-arm Cone-Beam CT for the Treatment of Liver Cancer
$483,871Xiaochuan Pan · University Of Chicago · R01 · FY2014 · CA
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia
$483,857Jorge A. Bezerra · Ut Southwestern Medical Center · R01 · FY2023 · DK
International Collaborative of prospective studies of HIV and Hepatitis in IDU
$483,785Kimberly Page · University Of California, San Francisco · R01 · FY2011 · DA
Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity
$483,735James P Luyendyk · Michigan State University · R01 · FY2024 · DK
Native Transformations Opiate Project
$483,676Stacy M. Rasmus · Northwest Indian College · S06 · FY2018 · GM
Brief Intervention to Reduce STDs in ER Drug Users
$483,602Edward Bernstein Bernstein · Boston Medical Center · R01 · FY2006 · DA
HEPADNAVIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA
$483,550Charles E. Rogler · Albert Einstein College Of Medicine · R01 · FY2008 · CA
A secure analytics platform to study the prognosis of people with HIV in the USA, Canada and Europe and comparative effectiveness of treatment regimens: the Antiretroviral Therapy Cohort Collaboration
$483,540Jonathan Sterne · University Of Bristol · R01 · FY2025 · AI